Delivery Order SPE2DR25D2011-SPE2DR26FADVH
- Not listed
- The Defense Logistics Agency awarded a $1,251.04 delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Xcopri 100 mg tablets (30-count package). This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 12, 2025, and represents a child delivery order under AmerisourceBergen's larger prime contract vehicle with DLA. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Xcopri 100 mg tablets (30-count units) with a contract ceiling value of $13,696.56. This firm fixed-price delivery order, valued at approximately $13.7K, represents a competitive award with no set-aside designation and is scheduled for completion by November 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Xcopri 50 mg tablets (30-count units) valued at $1,712.07 under a firm fixed-price arrangement. This non-set-aside competitive award reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The order is set for completion by December 23, 2025, with performance occurring at the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,712.07 to AmerisourceBergen Drug Corp for the supply of Xcopri 100 mg tablets (30-count units) on January 20, 2026, with an ultimate completion date of January 21, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and specifies performance at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (which operates under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,413.60 on August 25, 2025, for the supply of Xcopri 200 mg tablets (30-count). The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. This delivery order is issued under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,396.12 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count units). This competitively awarded, firm fixed price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,601.47 on December 2, 2025, for the supply of Xcopri 200 mg tablets (30-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 3, 2025, with performance to be executed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $10,595.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count units) with an ultimate completion date of October 30, 2025. This non-set-aside contract was competitively awarded on October 29, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a single transaction within the company's larger federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,916.59 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Xcopri 50 mg tablets (30-count packaging). This firm fixed-price delivery order, which is not a set-aside contract, represents a competitive award under DLA's broader pharmaceutical procurement framework. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 9,...
- The Defense Logistics Agency awarded a delivery order valued at $5,570.08 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This is a firm fixed-price, non-set-aside contract performed at the vendor's location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADVHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Xcopri 50 mg tablets (30-count units) with a contract value of $6,812.78. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 27, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026. The IDC enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. AmerisourceBergen's federal contract portfolio demonstrates significant capability in fulfilling critical pharmaceutical procurement needs across multiple therapeutic domains for the Department of Defense and related agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 1/25/26 |